Achim Wenzel is a scholar working on Molecular Biology, Neurology and Cancer Research.
According to data from OpenAlex, Achim Wenzel has authored 17 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Neurology and 4 papers in Cancer Research. Recurrent topics in Achim Wenzel's work include Neuroblastoma Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Achim Wenzel is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Achim Wenzel collaborates with scholars based in Germany, United Kingdom and Sweden. Achim Wenzel's co-authors include S. Matzku, W. Rudy, Helmut Ponta, Peter Herrlich, Ursula Günthert, Simone Reber, Margot Zöller, Martin Hofmann‐Apitius, U. Loos and M. Schwab and has published in prestigious journals such as Cell, The EMBO Journal and European Journal of Cancer.
In The Last Decade
Achim Wenzel
17 papers
receiving
2.3k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
19911.4k citationsUrsula Günthert, Martin Hofmann‐Apitius et al.Cellprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Achim Wenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Wenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Wenzel more than expected).
This network shows the impact of papers produced by Achim Wenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Wenzel. The network helps show where Achim Wenzel may publish in the future.
Co-authorship network of co-authors of Achim Wenzel
This figure shows the co-authorship network connecting the top 25 collaborators of Achim Wenzel.
A scholar is included among the top collaborators of Achim Wenzel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Achim Wenzel. Achim Wenzel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Dihlmann, Susanne, Lukas C. Amler, Manfred Schwab, & Achim Wenzel. (1997). Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue origin.. PubMed. 9(3). 119–27.4 indexed citations
7.
Lutz, W., et al.. (1996). Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells.. PubMed. 13(4). 803–12.260 indexed citations
Corvi, Raffaella, Stephen Breit, Achim Wenzel, et al.. (1995). Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.. PubMed. 10(6). 1081–6.98 indexed citations
10.
Wenzel, Achim, et al.. (1994). The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.. PubMed. 385. 59–66.2 indexed citations
11.
Cziepluch, Celina, et al.. (1993). Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.. PubMed. 8(10). 2833–8.11 indexed citations
12.
Günthert, Ursula, Martin Hofmann‐Apitius, W. Rudy, et al.. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65(1). 13–24.1441 indexed citations breakdown →
Hamann, Ute, Achim Wenzel, Rainer Frank, & Manfred Schwab. (1991). The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.. PubMed. 6(10). 1745–51.15 indexed citations
15.
Schweigerer, Lothar, Stephen Breit, Achim Wenzel, et al.. (1990). Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity.. PubMed. 50(14). 4411–6.111 indexed citations
16.
Matzku, S., et al.. (1989). Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies.. PubMed. 49(5). 1294–9.76 indexed citations
17.
Martinsson, Tommy, Franklin W. Stahl, Peter Pollwein, et al.. (1988). Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.. PubMed. 3(4). 437–41.17 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.